lisaftoclax,acalabrutinib,rituximab
ascentage pharmaceuticals,astrazeneca
['acalabrutinib', 'lisaftoclax', 'lymsm', 'cll', 'ritux']
#ash22 #lisaftoclax, a new #bcl2i in development in #cll #lymsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member